Global Competition Review recognises Cornerstone Research in the latest edition of the Economics 21 list.
London—For the 14th consecutive year, Global Competition Review (GCR) has named Cornerstone Research as one of the world’s leading economic consultancies. Compiled annually, the GCR Economics 21 survey recognises firms whose work addresses ‘some of the most complex competition matters in the world.’
In its 20th edition of the survey, GCR cites Cornerstone Research’s large team of competition economists; work on high-profile deals in the US, Canada and Europe; and experience with investigations and litigation matters across a variety of industries.
The GCR survey recognises Cornerstone Research’s significant antitrust expertise, as well as its work on some of the world’s most complex competition matters.
Cornerstone Research supported economic experts in numerous competition litigation matters and government investigations of alleged anticompetitive conduct. These matters spanned a variety of industries, including technology, healthcare, pharmaceuticals, financial instruments and media.
Cornerstone Research staff and affiliated experts also worked on cases at the intersection of antitrust and intellectual property, including competition matters involving standard essential patents.
The firm’s recent work includes:
- Twenty-two merger matters in the US, Canada, and Europe, including 21st Century Fox/The Walt Disney Company, Cigna/ Express Scripts and Commercial Metals Company/Gerdau.
- Two merger trials on behalf of the US Federal Trade Commission: FTC v. Wilhelmsen et al. and In the Matter of Otto Bock Healthcare North America Inc.
- Monopolization and exclusionary practices in Inline Packaging LLC v. Graphic Packaging International Inc.
- Trial testimony on liability and damages Shuffle Tech International LLC et al. v. Scientific Games Corp. et al.
- Antitrust issues arising in Oscar Insurance Company of Florida v. Blue Cross and Blue Shield of Florida, Inc. et al.
- The first collective proceedings order application in Europe, following an EU cartel settlement decision.
- Analysis of South Africa’s private healthcare market, as part of the Competition Commission of South Africa’s long-running healthcare market inquiry.
Read the firm’s full profile here.